It is believed that loss of SOD2 expression propagates early progression of metastatic diseases, while evidence shows that SOD2 levels increase in many tumors as progression goes from the early to late stage of the disease progression [9]. The gene discussed is SOD2; the disease is metastatic neoplasm.